Acute myeloid leukemia refers to acute myeloid leukemia, which is a malignant clonal disease that is usually severe and has a worse prognosis if accompanied by risk factors, so early treatment is recommended. Acute myeloid leukemia usually starts rapidly with sudden onset of high fever, severe anemia, bleeding, enlarged lymph nodes, liver and spleen. In severe cases, complications such as infection, hemorrhagic shock, dizziness and headache, convulsions and coma may occur. Without regular treatment, the average survival period is about 3 months, and death can even occur days after diagnosis, so acute myeloid leukemia should be treated as soon as possible. Specific therapeutic drugs include cytarabine, Zoerythromycin, Vinaclat, and Azacitidine. The following factors may worsen the prognosis: age ≥60 years; prior history of myelodysplastic syndrome or myeloproliferative neoplasms; previous associated or secondary AML; white blood cell count ≥100 x 10^9/L; combination of central nervous system leukemia; and incomplete remission after two courses of induction chemotherapy. Specific diagnosis and treatment should be made under the supervision of a physician.